Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
San Francisco, United States · Founded 2024
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Website
- uncommontherapeutics.com
- Last Round
- SeedFeb 2025
- Rounds
- 1
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Summary
Uncommon Therapeutics is a Biotech company based in San Francisco, United States, founded in 2024. Its most recent funding was a Seed round in Feb 2025. Investors include Y Combinator Continuity Fund and Pioneer Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...